High Risk - Long Term:
Large addressable market with un met needs.
Products already in the market with another ~11 products over the next few years.
Recent partnership established with Grace Medical being the largest in ENT sector.
Entering a number of new markets (countries) during FY19
A number of CE mark and FDA submissions expected in the same period.
BE AWARE: The company has only been listed for 2 months and the share price has appreciated ~2 1/2x Beiing a little patient and you may very well pick up at more attractive levels.